Research Article
[Retracted] Identification of MMP9 as a Novel Biomarker to Mitochondrial Metabolism Disorder and Oxidative Stress in Calcific Aortic Valve Stenosis
Figure 6
MMP9 was highly expressed in CAVS. (a) RT-PCR, (b) western blotting, and (c) immunohistochemistry were conducted to examine the expression of MMP9 in non-CAVS and CAVS samples, respectively (). (d) CT images confirmed an obvious calcified focus in CAVS samples, and TEM images showed mitochondria cristae damage in aortic valve tissues (). (a) compared with non-CAVS group.
(a) |
(b) |
(c) |
(d) |